Dr Indrani Bhattacharya

Dr Indrani Bhattacharya was appointed as a consultant clinical oncologist in Cambridge University Hospitals NHS Foundation Trust in August 2020. She trained at the University of Edinburgh followed by foundation training in Edinburgh and Fife, Scotland. She completed her Core Medical Training in Barts Health Trust followed by her Clinical Oncology training in London including in University College London Hospitals, Barts and Mount Vernon Cancer Centre. During her training she completed a 3-year CRUK funded Clinical Trials Fellowship and PhD at the Institute of Cancer Research’s Clinical Trials and Statistics Unit working within the portfolio of national breast radiotherapy trials including IMPORT LOW/HIGH and PRIMETIME. She led studies of patient-reported outcomes within the IMPORT trials and developed and tested decision aids in collaboration with patients in PRIMETIME.  

Dr Bhattacharya treats patients with early and advanced breast cancer with systemic and radiation therapies. She is the breast radiotherapy lead at Cambridge and is an expert reviewer for radiotherapy quality assurance in the PARABLE and ATNEC breast radiotherapy trials.  She is highly research active and is principle investigator for a number of breast cancer trials including PARABLE and KORTUC. She is a collaborator on the Lancet Breast Cancer Commission and chief investigator of the CASCARA (care and supportive needs in breast cancer) study. She is a member of the Breast Cancer Clinical Studies Group and is a trial management group member of several national breast cancer trials including PARABLE, FAST FORWARD, IMPORT, PRIMETIME and HER2RADICAL. She is the patient-reported outcomes lead in the PARABLE breast proton beam study. She is also leading the development of a study within a trial in HER2RADICAL investigating patient and clinician attitudes to risk. Her priority is to offer patients optimal therapies with the least side-effects ensuring patients are fully informed regarding their treatment options enabling a shared care decision for treatment. She is regularly invited to speak at national and international meetings and has been involved in the development of national and international guidelines in breast radiotherapy. She is involved in training and education and is a member of the Royal college of Radiologists Clinical Oncology Academic committee and is a FRCR examiner.